Nasopharyngeal Swabs Market

Nasopharyngeal Swabs Market (Application: Influenza, COVID-19, Respiratory Syncytial Virus, Bordetella Pertussis Infection, MRSA [Methicillin-resistant Staphylococcus Aureus], and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031


Nasopharyngeal Swabs Market – Scope of Report

TMR’s report on the global nasopharyngeal swabs market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global nasopharyngeal swabs market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global nasopharyngeal swabs market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the nasopharyngeal swabs market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global nasopharyngeal swabs market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global nasopharyngeal swabs market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global nasopharyngeal swabs market.

The report delves into the competitive landscape of the global nasopharyngeal swabs market. Key players operating in the global nasopharyngeal swabs market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global nasopharyngeal swabs market profiled in this report.

Key Questions Answered in Global Nasopharyngeal Swabs Market Report
  • What is the sales/revenue generated by nasopharyngeal swabs across all regions during the forecast period?
  • What are the opportunities in the global nasopharyngeal swabs market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Nasopharyngeal Swabs Market – Research Objectives and Research Approach

The comprehensive report on the global nasopharyngeal swabs market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global nasopharyngeal swabs market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global nasopharyngeal swabs market.


1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Nasopharyngeal Swabs Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Nasopharyngeal Swabs Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Industry Events
5.2. Technological Advancements
5.3. Epidemiology of Infectious Diseases, by Country/Region
5.4. COVID-19 Pandemic Impact on Industry
6. Global Nasopharyngeal Swabs Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type, 2017-2031
6.3.1. Foam Tipped Swabs
6.3.2. Non-woven Swabs
6.3.3. Others
6.4. Market Attractiveness Analysis, by Type
7. Global Nasopharyngeal Swabs Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2017-2031
7.3.1. Influenza
7.3.2. COVID-19
7.3.3. Respiratory Syncytial Virus
7.3.4. Bordetella Pertussis Infection
7.3.5. MRSA (Methicillin-Resistant Staphylococcus aureus)
7.3.6. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Nasopharyngeal Swabs Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017-2031
8.3.1. Hospitals
8.3.2. Clinics
8.3.3. Academia & Research Institutes
8.3.4. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Nasopharyngeal Swabs Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017-2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Nasopharyngeal Swabs Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Type, 2017-2031
10.2.1. Foam Tipped Swabs
10.2.2. Non-woven Swabs
10.2.3. Others
10.3. Market Value Forecast, by Application, 2017-2031
10.3.1. Influenza
10.3.2. COVID-19
10.3.3. Respiratory Syncytial Virus
10.3.4. Bordetella Pertussis Infection
10.3.5. MRSA (Methicillin-Resistant Staphylococcus aureus)
10.3.6. Others
10.4. Market Value Forecast, by End-user, 2017-2031
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Academia & Research Institutes
10.4.4. Others
10.5. Market Value Forecast, by Country, 2017-2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Nasopharyngeal Swabs Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Type, 2017-2031
11.2.1. Foam Tipped Swabs
11.2.2. Non-woven Swabs
11.2.3. Others
11.3. Market Value Forecast, by Application, 2017-2031
11.3.1. Influenza
11.3.2. COVID-19
11.3.3. Respiratory Syncytial Virus
11.3.4. Bordetella Pertussis Infection
11.3.5. MRSA (Methicillin-Resistant Staphylococcus aureus)
11.3.6. Others
11.4. Market Value Forecast, by End-user, 2017-2031
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Academia & Research Institutes
11.4.4. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Nasopharyngeal Swabs Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2017-2031
12.2.1. Foam Tipped Swabs
12.2.2. Non-woven Swabs
12.2.3. Others
12.3. Market Value Forecast, by Application, 2017-2031
12.3.1. Influenza
12.3.2. COVID-19
12.3.3. Respiratory Syncytial Virus
12.3.4. Bordetella Pertussis Infection
12.3.5. MRSA (Methicillin-Resistant Staphylococcus aureus)
12.3.6. Others
12.4. Market Value Forecast, by End-user, 2017-2031
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Academia & Research Institutes
12.4.4. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Nasopharyngeal Swabs Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2017-2031
13.2.1. Foam Tipped Swabs
13.2.2. Non-woven Swabs
13.2.3. Others
13.3. Market Value Forecast, by Application, 2017-2031
13.3.1. Influenza
13.3.2. COVID-19
13.3.3. Respiratory Syncytial Virus
13.3.4. Bordetella Pertussis Infection
13.3.5. MRSA (Methicillin-Resistant Staphylococcus aureus)
13.3.6. Others
13.4. Market Value Forecast, by End-user, 2017-2031
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Academia & Research Institutes
13.4.4. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Nasopharyngeal Swabs Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Type, 2017-2031
14.2.1. Foam Tipped Swabs
14.2.2. Non-woven Swabs
14.2.3. Others
14.3. Market Value Forecast, by Application, 2017-2031
14.3.1. Influenza
14.3.2. COVID-19
14.3.3. Respiratory Syncytial Virus
14.3.4. Bordetella Pertussis Infection
14.3.5. MRSA (Methicillin-Resistant Staphylococcus aureus)
14.3.6. Others
14.4. Market Value Forecast, by End-user, 2017-2031
14.4.1. Hospitals
14.4.2. Clinics
14.4.3. Academia & Research Institutes
14.4.4. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2022
15.3. Company Profiles
15.3.1. Thermo Fisher Scientific, Inc.
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. C. R. Bard, Inc. (Becton, Dickinson and Company)
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Medical Wire & Equipment (MWE)
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Titan Biotech Ltd.
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. COPAN Diagnostics, Inc.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Miraclean Technology Co., Ltd.
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Puritan Medical Products
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. YOCON Biology
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Trinity Biotech
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
15.3.10. VIRCELL S.L.
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. Financial Overview
15.3.10.4. SWOT Analysis
15.3.10.5. Strategic Overview
15.3.11. Quidel Corporation
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Product Portfolio
15.3.11.3. Financial Overview
15.3.11.4. SWOT Analysis
15.3.11.5. Strategic Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings